Dependence on Key Products: While Gilead Sciences Inc (NASDAQ:GILD) has a strong product lineup, its financial performance is ...

As a wave of patent expirations encroaches upon many of the world’s top drugmakers, companies will need to be diligent in ...

Detailed price information for Assembly Biosciences (ASMB-Q) from The Globe and Mail including charting and trades.

Products that are based on market cap weighted indexes ... followed by Bristol-Myers Squibb Co (BMY) and Gilead Sciences Inc (GILD).

The demand for eco-friendly vector control products Growing demand from consumers has increased ... Results for Twice-Yearly ...

Gilead Sciences, Inc. today presented the first in-depth look at full results from its pivotal Phase 3 PURPOSE 2 trial (NCT04925752), which is studying twice-yearly lenacapavir, the company's ...

Y-o-Y Growth and Strong Performance in 2024 The Small Molecule API market is anticipated to exhibit a Y-o-Y growth of 4.6% in ...